Author:
Lara-Corrales Irene,Bruckner Anna L.,Salas Alanis Julio Cesar,Mellerio Jemma E.,Pallison Francis,Murrell Dédée F.
Publisher
Springer Berlin Heidelberg
Reference131 articles.
1. Fine JD, Johnson L, Suchindran C, Bauer EA, Carter DM, McGuire J, et al. Extracutaneous manifestations of inherited epidermolysis bullosa. In: Fine JD, Bauer EA, McGuire J, Moshell A, editors. Epidermolysis bullosa: clinical, epidemiologic, and laboratory advances and the findings of the national epidermolysis bullosa registry. Baltimore: The Johns Hopkins University Press; 1999. p. 147–74.
2. Goodnough LT, Nissenson AR. Anemia and its clinical consequences in patients with chronic diseases. Am J Med. 2004;116(Suppl 7A):1S–2.
3. Fridge JL, Vichinsky EP. Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin. J Pediatr. 1998;132:871–3.
4. Atherton DJ, Cox I, Hann I. Intravenous iron (III) hydroxide-sucrose complex for anaemia in epidermolysis bullosa. Br J Dermatol. 1999;140:773.
5. Antunes I, Resende C, Granjo E, Mesquita-Guimares J. Recombinant human erythropoietin alpha in the correction of anaemia in epidermolysis bullosa. J Eur Acad Dermatol Venereol. 1999;12:181–2.